Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options.
Hazar YounisSe Eun HaBrian G JorgensenArushi VermaSeungil RoPublished in: Journal of personalized medicine (2022)
Maturity-Onset Diabetes of the Young (MODY) is a rare form of diabetes which affects between 1% and 5% of diagnosed diabetes cases. Clinical characterizations of MODY include onset of diabetes at an early age (before the age of 30), autosomal dominant inheritance pattern, impaired glucose-induced secretion of insulin, and hyperglycemia. Presently, 14 MODY subtypes have been identified. Within these subtypes are several mutations which contribute to the different MODY phenotypes. Despite the identification of these 14 subtypes, MODY is often misdiagnosed as type 1 or type 2 diabetes mellitus due to an overlap in clinical features, high cost and limited availability of genetic testing, and unfamiliarity with MODY outside of the medical profession. The primary aim of this review is to investigate the genetic characterization of the MODY subtypes. Additionally, this review will elucidate the link between the genetics, function, and clinical manifestations of MODY in each of the 14 subtypes. In providing this knowledge, we hope to assist in the accurate diagnosis of MODY patients and, subsequently, in ensuring they receive appropriate treatment.
Keyphrases
- type diabetes
- glycemic control
- cardiovascular disease
- healthcare
- blood glucose
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- metabolic syndrome
- dna methylation
- mass spectrometry
- diabetic rats
- mitochondrial dna
- adipose tissue
- insulin resistance
- prognostic factors
- combination therapy
- drug induced
- copy number
- genome wide